Upstream Chain Disposable Technology / Equipment Market, 2035 – ResearchAndMarkets.com

DUBLIN – (BUSINESS CHP) – The report “Market for disposable bioprocessing technology / equipment by product type, scale and key geographical regions: industry trends and global projections, 2022-2035” has been added to ResearchAndMarkets.com’s supply.

The Bioprocessing / Disposable Technology Market report includes an in-depth study of the current landscape and the likely future potential of developers of disposable technology and equipment upstream over the next 15 years. The study also includes an in-depth analysis that highlights the capabilities of various industry stakeholders involved in this field.

One of the key objectives of the report was to understand the main drivers of growth and to assess the future size of the upstream chain of disposable technologies / equipment. Based on a number of parameters, such as the overall market for upstream bioprocessing equipment and the share of disposable technology, we provided an informed assessment of market developments for the period 2022-2035.

Over time, biologics have gained considerable popularity due to their therapeutic efficacy, favorable safety profiles, and ability to treat a wide variety of indications for diseases that are otherwise difficult to treat. The success of these interventions has led stakeholders to modernize traditional technology for the production of organic products. Demand for increased productivity and flexibility, greater profitability and faster time to market further stimulates the replacement of traditional stainless steel equipment with disposable technologies.

These technologies have been well accepted for a relatively short period of time and have become an important tool in the development of various biotechnological processes. In addition, the ongoing COVID-19 pandemic has led the biopharmaceutical industry to move to disposable technology. These technologies not only reduce the footprint requirement, but also eliminate the cost of cleaning at the development stage.

In addition, single-use technologies have the potential to address a number of challenges associated with traditional bioprocessing systems and offer a variety of additional benefits, such as reduced water and energy consumption (by ~ 45%), lower initial investment costs (with 40%), less time to process organic products (by 33%), reduced risk of cross-contamination (by 8%) and increased potential for cost savings (by 30-40%).

The report includes detailed transcripts of interviews conducted with the following players in the industry:

  • Christopher Brau (scientist and R&D engineer, Thermo Fisher Scientific)

  • Nico Osterhuis (Technical Director and Co-Owner, Celltainer Biotech)

Key questions answered

  • Who are the leading players offering disposable bioprocessing technologies?

  • What are the different areas of application in which disposable biological treatment technologies can be used?

  • In which regions are most of the suppliers of disposable bioprocessing technologies located?

  • What is the relative competitiveness of different disposable biological treatment technologies?

  • What are the main characteristics of disposable bioreactors?

  • How has the landscape of the intellectual property of disposable biological treatment technologies evolved over the years?

  • What is the current supply and demand for the production of organic products through disposable biological processing technology?

  • How are current and future opportunities likely to be shared between key market segments?

Main topics covered:

1. FOREWORD

1.1. Overview

1.2. Scope of the report

1.3. research methodology

1.4. Key questions answered

1.5. Outlines of the head

2. SUMMARY

3. INTRODUCTION

3.1. Chapter review

3.2. Review of disposable biological treatment technology

3.3. The historical evolution of disposable bioprocessing technology

3.4. Types of disposable biological treatment technology

3.5. Applications of disposable biological treatment technology

3.6. Key challenges related to disposable bioprocessing technology

3.7. Future perspective

4. MARKET LANDSCAPE: SINGLE USE BIORAACTORS

4.1. Chapter review

4.2. Disposable bioreactors: List of products

4.3. Disposable bioreactors: Landscape of developers

5. MARKET LANDSCAPE: Disposable faucets

5.1. Chapter review

5.2. Disposable mixers: List of products

5.3. Disposable mixers: Landscape developers

6. MARKET LANDSCAPE: SINGLE USE SENSORS

6.1. Chapter review

6.2. Disposable sensors: List of products

6.3. Disposable sensors: Landscape of developers

7. MARKET LANDSCAPE: OTHER BIO-TREATMENT TECHNOLOGIES

7.1. Chapter review

7.2. Disposable media bags and containers

7.3. Disposable filters

7.4. Disposable sampling systems

7.5. Disposable connectors

8. ANALYSIS OF THE COMPETITIVENESS OF THE PRODUCT

8.1. Chapter review

8.2. Methodology

8.3. Assumptions / Key parameters

8.4. Product competitiveness analysis: Disposable bioreactors

8.5. Product Competitiveness Analysis: Disposable Mixers

8.6. Product Competitiveness Analysis: Disposable Sensors

9. SUPPLIERS OF BIO-PROCESSING TECHNOLOGY IN NORTH AMERICA: COMPANY PROFILES

9.1. Chapter review

9.2. Adventurer

9.3. Cytiva

9.4. Merck KGaA

9.5. Pall

9.6. Thermo Fisher Scientific

10. SUPPLIERS OF BIO-PROCESSING TECHNOLOGY TECHNOLOGY IN EUROPE: COMPANY PROFILES

10.1. Chapter review

10.2. Eppendorf

10.3. Saint-Gobain

10.4. Sartorius

11. SUPPLIERS OF SINGLE-USE ORGANIC TREATMENT TECHNOLOGY IN THE ASIA-PACIFIC REGION: COMPANY PROFILES

11.1. Chapter review

11.2. Satake Multimix

11.3. REPROCELLATION

11.4. Premas Biotech

12. PATENT ANALYSIS

12.1. Chapter review

12.2. Scope and methodology

12.3. Disposable biological treatment technology: patent analysis

12.4. Patent comparative analysis

13. BRAND POSITIONING MATRIX

13.1. Chapter review

13.2 Methodology

13.3. Key parameters

13.4. Single-use bioreactor developer brand positioning matrix

13.4.1. Brand positioning matrix: Pall Corporation

13.4.2. Brand positioning matrix: Eppendorf

13.4.3. Brand positioning matrix: Solaris Biotech

13.4.4. Brand positioning matrix: Sartorius Stedim Biotech

13.4.5. Brand positioning matrix: Applikon Biotechnology

13.4.6. Brand positioning matrix: CerCell

13.4.7. Brand positioning matrix: Synthecon

13.5. Single position mixer brand positioning matrix

13.5.1. Brand positioning matrix: Thermo Fisher Scientific

13.5.2. Brand positioning matrix: Merck Millipore

13.5.3. Brand positioning matrix: Cytiva Lifesciences

13.5.4. Brand positioning matrix: Pall Corporation

13.6. Disposable sensor developer brand positioning matrix

13.6.1. Brand positioning matrix: Masterflex

13.6.2. Brand positioning matrix: Levitronix

13.6.3. Brand positioning matrix: Malema Engineering

13.6.4. Brand positioning matrix: Parkin Hanifin

13.6.5. Brand positioning matrix: Pendo TECH

14. CASE: CAPACITY-SAVING POTENTIAL AND TIME POTENTIAL

14.1. Chapter review

14.2. Total potential for cost savings of disposable biotreatment technology, 2022-2035

14.2.1. Scenario 1

14.2.1.1. Key assumptions and methodology

14.2.1.2. Cost-saving potential with the acquisition of disposable technology upwards, 2022-2035

14.2.2. Scenario 2

14.2.2.1. Key assumptions and methodology

14.2.2.2. Cost-saving potential with the introduction of disposable biological treatment technology, 2022-2035

14.3. Total time-saving potential of disposable bioprocessing technology, 2022-2035

14.4. Concluding remarks

15. ANALYSIS OF DEMAND AND SUPPLY

15.1. Chapter review

15.2. Key assumptions and methodology

15.3. Global demand for organic products, 2022-2035

15.4. Concluding remarks

16. MARKET FORECAST AND ANALYSIS OF OPPORTUNITIES

16.1. Chapter review

16.2. Forecasting methodology and key assumptions

16.3. Global Disposable Bioprocessing Technology Market, 2022-2035

17. CONCLUSION

17.1. Chapter review

18. EXECUTIVE ENLIGHTENMENTS

18.1. Chapter review

18.2. Celltainer Biotech

18.2.1. Snapshot of the company

18.2.2. Transcript of the interview: Nico Osterhuis, technical director and co-owner

18.3. Thermo Fisher Scientific

18.3.1. Snapshot of the company

18.3.2. Transcript of the interview: Christopher Brau, scientist and R&D engineer

19. ANNEX 1: TABLE DATA

20. ANNEX 2: LIST OF COMPANIES AND ORGANIZATIONS

For more information on this report, visit https://www.researchandmarkets.com/r/8asrgo

Leave a Comment

Your email address will not be published.